Literature DB >> 20072116

Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder.

Virginia Soria1, Erika Martínez-Amorós, Geòrgia Escaramís, Joaquín Valero, Rosario Pérez-Egea, Cecilia García, Alfonso Gutiérrez-Zotes, Dolors Puigdemont, Mònica Bayés, José M Crespo, Lourdes Martorell, Elisabet Vilella, Antonio Labad, Julio Vallejo, Víctor Pérez, José M Menchón, Xavier Estivill, Mònica Gratacòs, Mikel Urretavizcaya.   

Abstract

Disruptions in circadian rhythms have been described in mood disorders (MD), but the involvement of genetic variation in genes pertaining to the molecular circadian machinery in the susceptibility to MD has not been conclusively determined. We examined 209 single-nucleotide polymorphisms (SNPs) covering 19 circadian genes (ADCYAP1, ARNTL, ARNTL2, BHLHB2, BHLHB3, CLOCK, CRY1, CRY2, CSNK1E, DBP, NPAS2, NR1D1, PER1, PER2, PER3, RORA, TIMELESS, VIP, and VIPR2) in a sample of 534 MD patients (335 with unipolar major mood depression (MDD) and 199 with bipolar disorder (BD)) and 440 community-based screened controls. Nominally, statistically significant associations were found in 15 circadian genes. The gene-wide test, corrected for the number of SNPs analyzed in each gene, identified significant associations in CRY1 (rs2287161), NPAS2 (rs11123857), and VIPR2 (rs885861) genes with the combined MD sample. In the MDD subsample, the same SNPs in CRY1 and NPAS2 of the combined sample remained associated, whereas in the BD subsample CLOCK (rs10462028) and VIP (rs17083008) were specifically associated. The association with an SNP located 3' near CRY1 gene in MDD remained statistically significant after permutation correction at experiment level (p=0.007). Significant additive effects were found between the SNPs that were statistically significant at the gene-wide level. We also found evidence of associations between two-marker haplotypes in CRY1 and NPAS2 genes and MD. Our data support the contribution of the circadian system to the genetic susceptibility to MD and suggest that different circadian genes may have specific effects on MD polarity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20072116      PMCID: PMC3055337          DOI: 10.1038/npp.2009.230

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  92 in total

Review 1.  Comparative studies of the biological distinction between unipolar and bipolar depressions.

Authors:  L N Yatham; M Srisurapanont; A P Zis; V Kusumakar
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

Review 2.  The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis.

Authors:  J C Wu; W E Bunney
Journal:  Am J Psychiatry       Date:  1990-01       Impact factor: 18.112

3.  Linkage studies of bipolar disorder in the region of the Darier's disease gene on chromosome 12q23-24.1.

Authors:  E Dawson; E Parfitt; Q Roberts; J Daniels; L Lim; P Sham; M Nöthen; P Propping; M Lanczik; W Maier
Journal:  Am J Med Genet       Date:  1995-04-24

4.  24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment.

Authors:  P Linkowski; J Mendlewicz; M Kerkhofs; R Leclercq; J Golstein; M Brasseur; G Copinschi; E Van Cauter
Journal:  J Clin Endocrinol Metab       Date:  1987-07       Impact factor: 5.958

Review 5.  Circadian rhythms in mammalian neurotransmitter receptors.

Authors:  A Wirz-Justice
Journal:  Prog Neurobiol       Date:  1987       Impact factor: 11.685

Review 6.  Sleep research in affective illness: state of the art circa 1987.

Authors:  C F Reynolds; D J Kupfer
Journal:  Sleep       Date:  1987-06       Impact factor: 5.849

7.  Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients.

Authors:  H S Akiskal; J D Maser; P J Zeller; J Endicott; W Coryell; M Keller; M Warshaw; P Clayton; F Goodwin
Journal:  Arch Gen Psychiatry       Date:  1995-02

Review 8.  The genetics of depression and manic-depressive disorder.

Authors:  P McGuffin; R Katz
Journal:  Br J Psychiatry       Date:  1989-09       Impact factor: 9.319

9.  Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population.

Authors:  A Lobo; M J Pérez-Echeverría; J Artal
Journal:  Psychol Med       Date:  1986-02       Impact factor: 7.723

Review 10.  Rhythm and blues. Neurochemical, neuropharmacological and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders.

Authors:  D Healy
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

View more
  119 in total

Review 1.  The role of sleep problems and circadian clock genes in childhood psychiatric disorders.

Authors:  Alexander Dueck; Johannes Thome; Frank Haessler
Journal:  J Neural Transm (Vienna)       Date:  2012-06-06       Impact factor: 3.575

2.  CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome.

Authors:  Leena Kovanen; Kati Donner; Mari Kaunisto; Timo Partonen
Journal:  Hypertens Res       Date:  2014-11-13       Impact factor: 3.872

3.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 4.  Circadian rhythms and mood regulation: insights from pre-clinical models.

Authors:  Colleen A McClung
Journal:  Eur Neuropsychopharmacol       Date:  2011-08-11       Impact factor: 4.600

5.  Testing the role of circadian genes in conferring risk for psychiatric disorders.

Authors:  Enda M Byrne; Andrew C Heath; Pamela A F Madden; Michele L Pergadia; Ian B Hickie; Grant W Montgomery; Nicholas G Martin; Naomi R Wray
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-03-29       Impact factor: 3.568

6.  Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.

Authors:  Chiara Fabbri; Concetta Crisafulli; Raffaella Calati; Diego Albani; Gianluigi Forloni; Marco Calabrò; Rosalba Martines; Siegfried Kasper; Joseph Zohar; Alzbeta Juven-Wetzler; Daniel Souery; Stuart Montgomery; Julien Mendlewicz; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-04       Impact factor: 5.270

Review 7.  Clock gene variants in mood and anxiety disorders.

Authors:  Timo Partonen
Journal:  J Neural Transm (Vienna)       Date:  2012-04-27       Impact factor: 3.575

8.  Cry1 and Tef gene polymorphisms are associated with major depressive disorder in the Chinese population.

Authors:  Ping Hua; Weiguo Liu; Donghui Chen; Yanyan Zhao; Ling Chen; Ning Zhang; Chun Wang; Suwan Guo; Li Wang; Hong Xiao; Sheng-Han Kuo
Journal:  J Affect Disord       Date:  2013-12-01       Impact factor: 4.839

9.  Common variants on Xq28 conferring risk of schizophrenia in Han Chinese.

Authors:  Emily H M Wong; Hon-Cheong So; Miaoxin Li; Quang Wang; Amy W Butler; Basil Paul; Hei-Man Wu; Tomy C K Hui; Siu-Chung Choi; Man-Ting So; Maria-Mercè Garcia-Barcelo; Grainne M McAlonan; Eric Y H Chen; Eric F C Cheung; Raymond C K Chan; Shaun M Purcell; Stacey S Cherny; Ronald R L Chen; Tao Li; Pak-Chung Sham
Journal:  Schizophr Bull       Date:  2013-09-16       Impact factor: 9.306

10.  The characteristics of sleep in patients with manifest bipolar disorder, subjects at high risk of developing the disease and healthy controls.

Authors:  Philipp S Ritter; Carolin Marx; Natalia Lewtschenko; Steffi Pfeiffer; Karolina Leopold; Michael Bauer; Andrea Pfennig
Journal:  J Neural Transm (Vienna)       Date:  2012-08-18       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.